TABLE 3.
Patient Characteristics and Indications | No. Bone Lesions Seen on 99mTc-MDP Scan | No. Bone Lesions Seen 99mTc-PSMA Scan | Paired t test P |
---|---|---|---|
Initial stage | |||
Stage 1–2 | 3 | 3 | |
Stage 3 | 9 | 7 | |
Stage 4 | 43 | 42 | |
0.225 | |||
Gleason score | |||
≤6 (low risk) | 1 | 0 | |
7 (intermediate risk | 44 | 41 | |
8–10 (high risk) | 11 | 11 | |
0.27 | |||
PSA | |||
1 (0–9.9 ng/mL) | 0 | 0 | |
2 (10–20 ng/mL) | 1 | 1 | |
3 (>20 ng/mL) | 54 | 51 | |
0.42 | |||
Indication | |||
Primary staging/restaging | 32 | 28 | |
Biochemical progression after radical therapy | 23 | 24 | |
0.66 |